More on KLRA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (9/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(NQ:KLRA)
Delayed: 18.55 +0.23 (1.26%)
Prev. Close $18.32  
Open$17.90 
52 Wk High$ 
52 Wk Low$ 
Day High$18.87 
Day Low$17.61 
P/E N/A  
EPS$ 
Volume342,892 

Friends, Peers and Foes (?): MBX, PFE, CMPS SPRO (more...)

Jul 8, 2026 04:20 PM Form 4 Kailera Therapeutics, For: Jul 06 Filed by: Tregoning Kathleen
Jul 8, 2026 04:15 PM Form 3 Kailera Therapeutics, For: Jun 29 Filed by: Tregoning Kathleen
Jun 29, 2026 07:30 AM Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer
Jun 11, 2026 04:05 PM Form 4 Kailera Therapeutics, For: Jun 09 Filed by: Renaud Ronald C JR
Jun 5, 2026 07:32 PM Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026
May 28, 2026 04:05 PM Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
May 26, 2026 04:41 PM Form 10-Q Kailera Therapeutics, For: Mar 31
May 26, 2026 04:33 PM Form 8-K Kailera Therapeutics, For: May 26
May 26, 2026 04:02 PM Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates
May 13, 2026 07:30 AM Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions
View All Articles

Entities mentioned with KLRA

View All Entities